{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:27:33Z","timestamp":1791228453636,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clindermatol.2020.10.016","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:55:40Z","timestamp":1602867340000},"page":"240-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa"],"prefix":"10.1016","volume":"39","author":[{"given":"Simone","family":"Garcovich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalma","family":"Malvaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.10.016_bb0005","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0010","first-page":"1017","article-title":"Hidradenitis suppurativa: review of the pathogenesis and treatment","volume":"15","author":"Kurayev","year":"2016","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jmg.21.4.281","article-title":"Familial hidradenitis suppurativa: evidence in favour of single gene transmission","volume":"21","author":"Fitzsimmons","year":"1984","journal-title":"J Med Genet."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","article-title":"The clinical genetics of hidradenitis suppurativa revisited","volume":"142","author":"Von Der Werth","year":"2000","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","article-title":"\u03b3-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis","volume":"133","author":"Pink","year":"2013","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0035","first-page":"1","article-title":"Crovella S","volume":"10","author":"Tricarico","year":"2019","journal-title":"An integrated approach to unravel hidradenitis suppurativa etiopathogenesis."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fmed.2017.00016","article-title":"Generalized comedones, acne, and hidradenitis suppurativa in a patient with an FGFR2 missense mutation","volume":"4","author":"Higgins","year":"2017","journal-title":"Front Med."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0045","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1111\/jdv.14860","article-title":"Patients affected by dent disease 2 could be predisposed to hidradenitis suppurativa","volume":"32","author":"Marzuillo","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0050","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jdv.14464","article-title":"Recognizing syndromic hidradenitis suppurativa: A review of the literature","volume":"31","author":"Gasparic","year":"2017","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0055","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/exd.12648","article-title":"Phenotypic heterogeneity implies heterogeneous pathogenic pathways in hidradenitis suppurativa","volume":"24","author":"Frew","year":"2015","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0060","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jaad.2015.07.047","article-title":"New insights into the diagnosis of hidradenitis suppurativa: clinical presentations and phenotypes","volume":"73","author":"van der Zee","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaad.2018.02.048","article-title":"Poor interrater reliability of hidradenitis suppurativa phenotypes","volume":"79","author":"van Straalen","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0070","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0075","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bjd.14364","article-title":"Hidradenitis suppurativa, neutrophilic dermatoses and autoinflammation: what\u2019s the link?","volume":"174","author":"Marzano","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0085","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0090","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/ijd.13503","article-title":"Familial Mediterranean fever patients with hidradenitis suppurativa","volume":"56","author":"Vural","year":"2017","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0095","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jid.2017.04.024","article-title":"Hidradenitis suppurativa is associated with familial Mediterranean fever\u2014a population-based study","volume":"137","author":"Hodak","year":"2017","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jbspin.2016.02.021","article-title":"Association of hidradenitis suppurativa and familial Mediterranean fever: a case series of 6 patients","volume":"84","author":"Abbara","year":"2017","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0105","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case\u2013control study","volume":"180","author":"Vural","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0110","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jaci.2018.01.010","article-title":"Hidradenitis suppurativa as an autoinflammatory keratinization disease","volume":"141","author":"De Vita","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0115","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.14691","article-title":"Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation","volume":"175","author":"Marzano","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/bjd.18445","article-title":"A novel NCSTN missense mutation in the signal peptide domain causes hidradenitis suppurativa, which has features characteristic of an autoinflammatory keratinization disease","volume":"182","author":"Takeichi","year":"2020","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-017-3921-0","article-title":"Autoinflammation in rheumatic and musculoskeletal disorders","volume":"38","author":"Misra","year":"2018","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/intimm\/dxy021","article-title":"Using genes to triangulate the pathophysiology of granulomatous autoinflammatory disease: NOD2, PLCG2 and LACC1","volume":"30","author":"Szymanski","year":"2018","journal-title":"Int Immunol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0140","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3389\/fimmu.2019.01059","article-title":"Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases","volume":"10","author":"Marzano","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)\u2014a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0150","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s10620-009-0929-7","article-title":"Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1\/PSTPIP1 gene is associated with aseptic abscesses and with Crohn disease in French patients","volume":"55","author":"Andr\u00e9","year":"2010","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0155","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","article-title":"Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases","volume":"93","author":"Marzano","year":"2014","journal-title":"Medicine."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0160","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.15226","article-title":"Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis)","volume":"176","author":"Marzano","year":"2017","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/bjd.14383","article-title":"PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome","volume":"175","author":"Calderon-Castrat","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12016-012-8351-x","article-title":"Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet\u2019s syndrome: a comprehensive review and disease classification criteria","volume":"45","author":"Marzano","year":"2013","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0175","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0180","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","article-title":"PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition","volume":"72","author":"Saraceno","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","article-title":"Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis","volume":"18","author":"Bruzzese","year":"2012","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0190","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000443648","article-title":"PASS syndrome: an IL-1-driven autoinflammatory disease","volume":"232","author":"Leuenberger","year":"2016","journal-title":"Dermatology."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0195","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjd.13668","article-title":"First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome","volume":"173","author":"Duchatelet","year":"2015","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/exd.12098","article-title":"Impaired notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology","volume":"22","author":"Melnik","year":"2013","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0205","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1111\/bjd.15740","article-title":"PASH syndrome (pyoderma gangrenosum, acne and hidradenitis suppurativa): a disease with genetic heterogeneity","volume":"178","author":"Sonbol","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0210","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjd.18003","article-title":"PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens","volume":"181","author":"Gottlieb","year":"2019","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0215","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.ajpath.2010.12.053","article-title":"Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am J Pathol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0220","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ajpath.2010.12.035","article-title":"Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6\/SHP1) may contribute to neutrophilic dermatoses","volume":"178","author":"Nesterovitch","year":"2011","journal-title":"Am J Pathol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0225","first-page":"187","article-title":"Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases TT - Le syndrome acn\u00e9 pustulose hyperostose ost\u00e9ite (SAPHO). R\u00e9sultats d\u2019une enqu\u00eate nationale. 85 observations","volume":"54","author":"Chamot","year":"1987","journal-title":"Rev Rhum Mal Osteoartic."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3899\/jrheum.090456","article-title":"Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes","volume":"37","author":"Hurtado-Nedelec","year":"2010","journal-title":"J Rheumatol."},{"issue":"suppl 6","key":"10.1016\/j.clindermatol.2020.10.016_bb0235","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jdv.15849","article-title":"Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate","volume":"33","author":"Genovese","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ijd.13740","article-title":"SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature","volume":"57","author":"Vekic","year":"2018","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0245","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3899\/jrheum.171007","article-title":"Is SAPHO syndrome linked to PASH syndrome and hidradenitis suppurativa by nicastrin mutation? A case report","volume":"45","author":"Li","year":"2018","journal-title":"J Rheumatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pde.14012","article-title":"Follicular occlusion disorders in Down syndrome patients","volume":"37","author":"Firsowicz","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bjd.15770","article-title":"Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis","volume":"178","author":"Garg","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2340\/00015555-3095","article-title":"Prevalence and description of hidradenitis suppurativa in down syndrome: a cross-sectional study of 783 subjects","volume":"99","author":"Poizeau","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0270","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.febslet.2011.02.023","article-title":"Tenascin-C triggers fibrin accumulation by downregulation of tissue plasminogen activator","volume":"585","author":"Brellier","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000487799","article-title":"Hidradenitis suppurativa associated with Down syndrome is characterized by early age at diagnosis","volume":"234","author":"Giovanardi","year":"2018","journal-title":"Dermatology."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5826\/dpc.0903a03","article-title":"Disseminate recurrent folliculitis and hidradenitis suppurativa are associated conditions: results from a retrospective study of 131 patients with Down syndrome and a cohort of 12,351 pediatric controls","volume":"9","author":"Sechi","year":"2019","journal-title":"Dermatol Pract Concept."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0285","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/bjd.12887","article-title":"The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link?","volume":"170","author":"Blok","year":"2014","journal-title":"Br J Dermatol."},{"issue":"suppl 6","key":"10.1016\/j.clindermatol.2020.10.016_bb0290","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jdv.15824","article-title":"A case of hidradenitis suppurativa linked to trisomy 1q","volume":"33","author":"Skroza","year":"2019","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0295","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2230.2004.01631.x","article-title":"Hidradenitis suppurativa, Dowling-Degos and multiple epidermal cysts: a new follicular occlusion triad","volume":"29","author":"Loo","year":"2004","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0300","first-page":"446","article-title":"Reticulate pigmented anomaly of the flexures (Dowling-Degos disease): a case report associated with hidradenitis suppurativa and squamous cell carcinoma","volume":"45","author":"Weber","year":"1990","journal-title":"Cutis."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0305","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2340\/00015555-3225","article-title":"Dowling-Degos disease and hidradenitis suppurativa. Epidemiological and clinical study of 15 patients and review of the literature","volume":"99","author":"Agut-Busquet","year":"2019","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0310","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.jid.2017.05.021","article-title":"PSENEN mutation carriers with co-manifestation of acne inversa (AI) and Dowling-Degos disease (DDD): is AI or DDD the subphenotype?","volume":"137","author":"Li","year":"2017","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0315","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1346-8138.14722","article-title":"Hidradenitis suppurativa of the nape: description of an atypical phenotype related to severe early-onset disease in men","volume":"46","author":"Agut-Busquet","year":"2019","journal-title":"J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0320","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1172\/JCI90667","article-title":"Mutations in \u03b3-secretase subunit\u2013encoding PSENEN underlie Dowling-Degos disease associated with acne inversa","volume":"127","author":"Ralser","year":"2017","journal-title":"J Clin Invest."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0325","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/bjd.16264","article-title":"Novel POFUT1 mutation associated with hidradenitis suppurativa\u2013Dowling\u2013Degos disease firm up a role for Notch signalling in the pathogenesis of this disorder","volume":"178","author":"Gonz\u00e1lez-Villanueva","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0330","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.16000","article-title":"A phenotype combining hidradenitis suppurativa with Dowling\u2013Degos disease caused by a founder mutation in PSENEN","volume":"178","author":"Pavlovsky","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0340","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/17512433.2017.1356719","article-title":"Drug management of neutrophilic dermatoses","volume":"10","author":"Garcovich","year":"2017","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0345","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamadermatol.2017.2392","article-title":"Canakinumab for severe hidradenitis suppurativa: preliminary experience in 2 cases","volume":"153","author":"Houriet","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0350","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0355","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1111\/ijd.14596","article-title":"Long-term therapy with anakinra in hidradenitis suppurativa in three patients","volume":"58","author":"Andre","year":"2019","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0360","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jid.2019.10.024","article-title":"A phase II, open label study of bermekimab in patients with hidradenitis suppurativa shows resolution of inflammatory lesions and pain","volume":"140","author":"Gottlieb","year":"2020","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0365","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jaad.2015.07.040","article-title":"Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients","volume":"73","author":"Join-Lambert","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0370","first-page":"216","article-title":"Is PASH syndrome a biofilm disease? A case series and review of the literature","volume":"30","author":"Ead","year":"2018","journal-title":"Wounds Compend Clin Res Pract."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0375","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0380","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjd.13999","article-title":"Dissecting cellulitis of the scalp: a retrospective study of 51 patients and review of literature","volume":"174","author":"Badaoui","year":"2016","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0385","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/1346-8138.14998","article-title":"Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: a case report and review of published cases","volume":"46","author":"Takahashi","year":"2019","journal-title":"J Dermatol."},{"key":"10.1016\/j.clindermatol.2020.10.016_bb0390","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archdermatol.2010.16","article-title":"3 cases of dissecting cellulitis of the scalp treated with adalimumab: control of inflammation within residual structural disease","volume":"146","author":"Navarini","year":"2010","journal-title":"Arch Dermatol."}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:42Z","timestamp":1760033802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0738081X20301954"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.016","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}